BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 476597)

  • 1. Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC).
    Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
    Cancer; 1979 Sep; 44(3):858-63. PubMed ID: 476597
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracil.
    Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
    Cancer Treat Rep; 1978 Oct; 62(10):1603-5. PubMed ID: 361230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell bronchogenic carcinoma. A prolonged remission following chemotherapy.
    Cohen MH
    JAMA; 1977 Jun; 237(23):2528. PubMed ID: 576972
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the effectiveness of N-nitrosomethylurea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea combined with cyclophosphane in inoperable lung cancer].
    Assekritova IV; Perevodchikova NI; Batinov IN; Bychkov MB; Vaarik KhM
    Vestn Akad Med Nauk SSSR; 1978; (9):87-90. PubMed ID: 214971
    [No Abstract]   [Full Text] [Related]  

  • 7. Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapy.
    Mulder JH; Smink T; Van Putten LM
    Eur J Cancer (1965); 1977 Oct; 13(10):1123-31. PubMed ID: 270404
    [No Abstract]   [Full Text] [Related]  

  • 8. MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung: low response rate in a Cooperative Group Study. Eastern Cooperative Oncology Group.
    Vogl SE; Mehta CR; Cohen MH
    Cancer; 1979 Sep; 44(3):864-8. PubMed ID: 476598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of advanced colorectal carcinoma with 5-fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate.
    White DR; Richards F; Muss HB; Cooper MR; Spurr CL
    Cancer; 1980 Feb; 45(4):662-5. PubMed ID: 6986968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
    Eagan RT; Frytak S; Creagan ET; Ingle JN; Kvols LK; Coles DT
    Cancer Treat Rep; 1979; 63(9-10):1589-91. PubMed ID: 227597
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
    Bernath AM; Cohen MH; Ihde DC; Fossieck BE; Matthews MJ; Minna JD
    Cancer Treat Rep; 1976 Sep; 60(9):1393-4. PubMed ID: 189924
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer.
    Cedermark BJ; Gunven P; Hammarberg C
    J Surg Oncol; 1983 Feb; 22(2):125-8. PubMed ID: 6296546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell carcinoma of the lung: a combined modality treatment.
    van Houtte P; Tancini G; de Jager R; Lustman-Maréchal J; Milani F; Bonadonna G; Kenis Y
    Eur J Cancer (1965); 1979 Sep; 15(9):1159-65. PubMed ID: 93543
    [No Abstract]   [Full Text] [Related]  

  • 14. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.
    Chahinian AP; Mandel EM; Holland JF; Jaffrey IS; Teirstein AS
    Cancer; 1979 May; 43(5):1590-7. PubMed ID: 221093
    [No Abstract]   [Full Text] [Related]  

  • 15. MItomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma.
    Bonomi PD; Chandra G; Rossof AH; Klaassen D
    Cancer Chemother Pharmacol; 1980; 5(1):39-42. PubMed ID: 7006846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination.
    Hansen HH; Dombernowsky P; Hansen M; Hirsch F
    Ann Intern Med; 1978 Aug; 89(2):177-81. PubMed ID: 209710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Coltman C; Bottomley R; Wilson H; Bonnet J; Thigpen T; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1978 Sep; 42(3):1228-33. PubMed ID: 359121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.